Pfizer is on the lookout for further acquisitions in the area of emerging markets, established products, inflammatory diseases as well as cancer and alzheimer, German daily Handelsblatt said, citing the drug maker's chief financial officer. Pfizer CFO Frank D'Amelio told Handelsblatt that the world's largest drug maker was interested in bolt-on acquisitions. On Tuesday Pfizer posted higher-than-expected quarterly results.
This interview covers key results of the study ‘Success Factor Supply Chain Management and Logistics in the Chemical Industry 2024’ by Solventure, Aimms and Miebach.
Novo Nordisk recently announced changes to its executive leadership and Board of Directors.
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK, and Switzerland
The versatile material polymethyl methacrylate (PMMA) is particularly impressive due to its durability and outstanding recyclability.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
